Portuguese cohort: raltegravir with optimized background therapy (OBT) in multiple-experienced HIV1- and HIV2-infected patients

por Doroana, M, Piñeiro, C, Maltez, F, Fonseca, P, Oliveira, J, Mansinho, K, Horta, A, Teófilo, E, Aguas, M, Germano, I, Faria, D
Publicado 2010

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study

por Raben, D., Mocroft, A., Rayment, M., Mitsura, V. M., Hadziosmanovic, V., Sthoeger, Z. M., Palfreeman, A., Morris, S., Kutsyna, G., Vassilenko, A., Minton, J., Necsoi, C., Estrada, V. P., Grzeszczuk, A., Johansson, V. Svedhem, Begovac, J., Ong, E. L. C., Cabié, A., Ajana, F., Celesia, B. M., Maltez, F., Kitchen, M., Comi, L., Dragsted, U. B., Clumeck, N., Gatell, J., Gazzard, B., d’Arminio Monforte, A., Rockstroh, J., Yazdanpanah, Y., Champenois, K., Jakobsen, M. L., Sullivan, A., Lundgren, J. D.
Publicado 2015